SEC Form D · filed December 4, 2024
Aclaris Therapeutics, Inc
Offering
$80.0M
Sold
$80.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WAYNE, PA
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗